Bart van de Sluis, PhD
Rijksuniversiteit Groningen
H-index: 47
Europe-Netherlands
Top articles of Bart van de Sluis, PhD
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Changes in bile acid composition are correlated with reduced intestinal cholesterol uptake in intestine-specific WASH-deficient mice | Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids | Andries Heida Theo van Dijk Marieke Smit Martijn Koehorst Mirjam Koster | 2024/3/1 |
VLDL Biogenesis and Secretion: it takes a village | Willemien van Zwol Bart van de Sluis Henry N Ginsberg Jan Albert Kuivenhoven | 2024/1/19 | |
Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathway | Pharmacological research | Zhixiong Ying Robin van Eenige Rosa Beerepoot Mariëtte R Boon Niels J Kloosterhuis | 2023/1/1 |
The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR … | Toxicology and Applied Pharmacology | Andrea C Postmus Janine K Kruit Roos E Eilers Rick Havinga Mirjam H Koster | 2023/6/1 |
The endosomal sorting complex Retromer has a central role in systemic cholesterol homeostasis by controlling endo-lysosomal cholesterol transport in hepatocytes | bioRxiv | Dyonne Y Vos Markus G Barbosa Andries H Heida W Alfredo Rios-Ocampo Joel J Tissink | 2023/8/9 |
Cargo-specific role for retriever subunit VPS26C in hepatocyte lipoprotein receptor recycling to control postprandial triglyceride-rich lipoproteins | Arteriosclerosis, thrombosis, and vascular biology | Dyonne Y Vos Melinde Wijers Marieke Smit Nicolette Huijkman Niels J Kloosterhuis | 2023/1 |
Mitochondrial DNA methylation in metabolic associated fatty liver disease | Frontiers in nutrition | Archibold Mposhi Fabian Cortés-Mancera Janette Heegsma Vincent E De Meijer Bart Van de Sluis | 2023/5/25 |
Prevention of atherosclerosis and hepatic steatosis by combined, liver-specific deletion of GPR146 and ANGPTL3 | Atherosclerosis | U Tharehalli Mathada A Rimbert B Zhang N Kloosterhuis N Huijkman | 2023/8/1 |
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia | Cancer & metabolism | Martijn GS Rutten Yu Lei Joanne H Hoogerland Vincent W Bloks Hong Yang | 2023/4/21 |
GPR146 and HDL metabolism | Atherosclerosis | B Zhang U Tharehalli Mathada N Loaiza L Martinez N Huijkman | 2023/8/1 |
Selective Hepatic Cbs Knockout Aggravates Liver Damage, Endothelial Dysfunction and ROS Stress in Mice Fed a Western Diet | International Journal of Molecular Sciences | Sebastiaan Lambooy Andries Heida Christian Joschko Dalibor Nakladal Azuwerus van Buiten | 2023/4/10 |
Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in the brain | Life science alliance | Esther Stroo Leen Janssen Olga Sin Wytse Hogewerf Mirjam Koster | 2023/7/1 |
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism | Hepatology | Audrey Deprince Nathalie Hennuyer Sander Kooijman Amanda CM Pronk Eric Baugé | 2023/4/1 |
Characterization of a novel bile salt export pump deficiency mouse model with the p. E297g mutation | Antonia Felzen Milaine Hovingh Rick Havinga Niels Mulder Martijn Koehorst | 2023/6 | |
Prevention of Triglyceridemia by (Non-) Anticoagulant Heparin (oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis | Frontiers in Cell and Developmental Biology | Pragyi Shrestha Kirankumar Katta Ditmer Talsma Annamaria Naggi Jan-Luuk Hillebrands | 2022/3/7 |
The endosomal sorting protein VPS35 controls lipid homeostasis through regulating hepatic lysosomal function | Atherosclerosis | DY Vos A Heida M Koster J Tissink KB Kuentzel | 2022/8/1 |
Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism | Scientific reports | Maaike Blankestijn Vincent W Bloks Dicky Struik Nicolette Huijkman Niels Kloosterhuis | 2022/2/15 |
Hepatic SMLR1 ablation fully protects against diet-induced atherosclerosis but causes hepatosteatosis via reduced VLDL secretion | Atherosclerosis | W Van Zwol A Rimbert JC Wolters V Bloks NJ Kloosterhuis | 2022/8/1 |
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion. | Hepatology (Baltimore, Md.) | Willemien van Zwol Antoine Rimbert Justina C Wolters Marieke Smit Vincent W Bloks | 2022/10/12 |
Posttranscriptional regulation of the human LDL receptor by the U2-spliceosome | Circulation research | Paolo Zanoni Grigorios Panteloglou Alaa Othman Joel T Haas Roger Meier | 2022/1/7 |
Co-Authors
